PTC THERAPEUTICS, INC.
PTC THERAPEUTICS, INC. (PTCT) is a publicly traded company in the Unknown sector. Across all available filings, 34 corporate insiders have executed 1120 transactions totaling $267.2M, demonstrating a bearish sentiment with -$152.5M in net insider flow. The most recent transaction on Jan 8, 2026 involved a sale of 866 shares valued at $66.2K.
PTCT Insider Activity Summary
Who Is Buying PTCT Stock?
No significant insider buying has been recorded for PTCT in the recent period.
Who Is Selling PTCT Stock?
No significant insider selling has been recorded for PTCT in the recent period.
Is PTC THERAPEUTICS, INC. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for PTCT is bearish with an Insider Alignment Score of 21/100 and a net flow of -$152.5M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
PTCT Frequently Asked Questions
Understanding PTCT Insider Activity
Insider trading at PTC THERAPEUTICS, INC. (PTCT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 34 insiders are actively trading PTCT stock, having executed 1120 transactions in the past 90 days. The most active insider is Stuart Walter Peltz (Executive), who has made 193 transactions totaling $115.1M.
Related Tools
Track PTC THERAPEUTICS, INC. Insider Activity
Get notified when executives and directors at PTCT file new Form 4 transactions